1h Free Analyst Time
Global Endovenous Ablation Devices Market 2021-2025Speak directly to the analyst to clarify any post sales queries you may have.
The publisher has been monitoring the endovenous ablation devices market and it is poised to grow by $ 156.60 mn during 2021-2025 progressing at a CAGR of 6% during the forecast period. The report on endovenous ablation devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of CVI, growing demand for MI endovenous ablation procedures, and technological advances in endovascular ablation devices. In addition, increasing prevalence of CVI is anticipated to boost the growth of the market as well.
The endovenous ablation devices market analysis includes product segment and geographical landscapes.
The endovenous ablation devices market is segmented as below:
By Product
- EVLT devices
- RFA devices
- NTNT devices
By Geographical Landscapes
- North America
- Europe
- Asia
- ROW
This study identifies the increasing popularity of performing endovenous procedures in an outpatient setting as one of the prime reasons driving the endovenous ablation devices market growth during the next few years. Also, emergence of endovenous steam ablation (EVSA) as an alternative to EVLA and RFA, and strategic partnerships, M&A, and marketing initiatives by vendors will lead to sizable demand in the market.
The report on endovenous ablation devices market covers the following areas:
- Endovenous ablation devices market sizing
- Endovenous ablation devices market forecast
- Endovenous ablation devices market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading endovenous ablation devices market vendors that include AngioDynamics Inc., AtriCure Inc., Eufoton srl, Johnson & Johnson, Medtronic Plc, Merit Medical Systems Inc., RF Medical Co. Ltd. , Sciton Inc., Teleflex Inc., and Venclose Inc. . Also, the endovenous ablation devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Table of Contents
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Product
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global endovenous ablation devices market: AngioDynamics Inc., AtriCure Inc., Eufoton srl, Johnson & Johnson, Medtronic Plc, Merit Medical Systems Inc., RF Medical Co. Ltd. , Sciton Inc., Teleflex Inc., and Venclose Inc.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is increasing popularity of performing endovenous procedures in an outpatient setting.'
According to the report, one of the major drivers for this market is the increasing prevalence of CVI.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AngioDynamics Inc.
- AtriCure Inc.
- Eufoton srl
- Johnson & Johnson
- Medtronic Plc
- Merit Medical Systems Inc.
- RF Medical Co. Ltd.Â
- Sciton Inc.
- Teleflex Inc.
- Venclose Inc.Â